DCT
3:15-cv-03322
Horizon Pharma Inc v. Actavis Laboratories FL Inc
Log In
Overview
Analysis
General
Parties
Attorneys
Patents
Related Cases
Dockets
General
Filed
05/13/15
Cause of Action
Patent Infringement
Sector
Biotech
Status
Closed (02/09/17)
Patent Owner
Operating Company
(L)
PACER
3:15-cv-03322
Appeals
17-1604
,
17-1605
,
17-1606
,
17-1607
,
17-1608
,
17-1610
,
17-1611
,
17-1612
,
17-1614
,
17-1616
Court
D. New Jersey
Judge
Period
PO Win Rate
Mary L. Cooper
--
64%
Plaintiff
Party
Name
Ratings
Horizon Pharma USA Inc
L3
B
Pozen Inc
L1
C
Show all (0 more)
Attorney
Name
Ratings
Finnegan Henderson Farabow Garrett & Dunner LLP
L5
A
James B. Monroe
L5
A
Danielle C. Pfifferling
L5
C
Cooley LLP
L5
A
Ellen A. Scordino
L5
B
Ricardo Rodriguez
L5
E
Adam Pivovar
L4
A
Susan Krumplitsch
L3
B
Baker Botts LLP
L5
B
Stephen M. Hash
L5
E
Jeffrey S. Gritton
L4
B
Samoneh Kadivar
L3
C
McCarter & English LLP
L4
A
John E. Flaherty
L4
A
Ravin R. Patel
L4
B
Guillermo C. Artiles
L1
D
Show all (6 more)
Defendant
Party
Name
Ratings
Actavis Laboratories FL Inc
L5
E
Actavis Inc
L5
E
Actavis Pharma Inc
L2
E
Show all (1 more)
Attorney
Name
Ratings
Fleming Ruvoldt PLLC
Local
L1
B
Robert J. Fettwei
L2
C
Maddox Edwards PLLC
L1
C
Steven A. Maddox
L5
E
Jeremy J. Edwards
L4
E
Matthew C. Ruedy
L2
D
Walsh Pizzi Oreilly Falanga LLP
Local
L1
C
Liza M. Walsh
L3
B
Christine I. Gannon
L1
D
Selina M. Ellis
L1
D
Show all (0 more)